The benefit seems durable, but one expert says patients should be aware there’s “some risk of stroke” during the procedure.

The overall evidence for the procedure is “insufficient” at present, but good enough to allow coverage, the agency says.

Some believe that future studies are still needed to tease out whether there are high-risk subgroups who will benefit.

A true test of durability will take many more years, but if the valve holds up, it’s “potentially a game changer,” say ...

When encountering elderly ACS patients, clinical judgement is important given the risks of bleeding, says Arnold Seto.

Permanent pacemaker rates were nearly 18% at 30 days but came down as sites gained experience with the new device.

There have been three deaths and no serious injuries tied to a problem affecting detection of the pumps, according to Abiomed ...

The data indicate it’s worth a shot to try TEER in many with secondary MR, but clinical judgement is critical.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...